FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to...
lymphoma
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
lenalidomide capsules, for oral use
A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of follicular lymphoma, marginal zone lymphoma, mantle...
Venetoclax tablets
A drug used alone or with other drugs to treat certain adults with acute myeloid leukemia that is newly diagnosed and adults with chronic lymphocytic leukemia or small...
Vorinostat Capsules
A drug used to treat cutaneous T-cell lymphoma that came back, got worse, or did not get better during or after treatment with two systemic therapies. It is also being...
Rituximab injection, for intravenous
A drug used alone or with other drugs under the brand names Riabni, Rituxan, Ruxience, and Truxima to treat certain types of B-cell non-Hodgkin lymphoma, chronic...
Pralatrexate injection Solution for intravenous injection
A drug used to treat peripheral T-cell lymphoma (a fast-growing form of non-Hodgkin lymphoma) that recurred (came back) or did not get better with other anticancer...
Vinblastine sulphate Injection
A drug used to treat certain types of breast cancer, choriocarcinoma (a type of gestational trophoblastic tumor), Hodgkin lymphoma, non-Hodgkin lymphoma, Kaposi...
brentuximab vedotin for injection
On March 20, 2018, the Food and Drug Administration approved brentuximab vedotin for injection,for intravenous use,to treat adult patients with previously untreated...